{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "regularMarketChangePercent": 1.7316002, "regularMarketPrice": 4.7, "earningsTimestamp": 1683576300, "earningsTimestampStart": 1691578740, "earningsTimestampEnd": 1692014400, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -2.11, "epsForward": -2.88, "epsCurrentYear": -2.23, "priceEpsCurrentYear": -2.107623, "sharesOutstanding": 45093200, "bookValue": 4.498, "fiftyDayAverage": 4.5744, "fiftyDayAverageChange": 0.12559986, "fiftyDayAverageChangePercent": 0.027457124, "twoHundredDayAverage": 4.07585, "twoHundredDayAverageChange": 0.6241498, "twoHundredDayAverageChangePercent": 0.15313365, "marketCap": 212360096, "forwardPE": -1.6319443, "priceToBook": 1.0449088, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "averageAnalystRating": "1.3 - Strong Buy", "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1588140000000, "priceHint": 4, "marketState": "REGULAR", "exchange": "FRA", "shortName": "ORIC PHARMAC.INC.DL-,0001", "longName": "ORIC Pharmaceuticals, Inc.", "messageBoardId": "finmb_303713108", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "esgPopulated": false, "regularMarketChange": 0.07999992, "regularMarketTime": 1683899564, "regularMarketDayHigh": 4.7, "regularMarketDayRange": "4.68 - 4.7", "regularMarketDayLow": 4.68, "regularMarketVolume": 300, "regularMarketPreviousClose": 4.62, "bid": 4.68, "ask": 4.76, "fullExchangeName": "Frankfurt", "financialCurrency": "USD", "regularMarketOpen": 4.68, "averageDailyVolume3Month": 5, "averageDailyVolume10Day": 0, "fiftyTwoWeekLowChange": 2.3199997, "fiftyTwoWeekLowChangePercent": 0.97478974, "fiftyTwoWeekRange": "2.38 - 6.4", "fiftyTwoWeekHighChange": -1.7000003, "fiftyTwoWeekHighChangePercent": -0.26562503, "fiftyTwoWeekLow": 2.38, "fiftyTwoWeekHigh": 6.4, "symbol": "4TZ.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "240 East Grand Avenue", "address2": "2nd Floor", "city": "South San Francisco", "state": "CA", "zip": "94080", "country": "United States", "phone": "650 388 5600", "website": "https://www.oricpharma.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment regimens; ORIC-944, an allosteric inhibitor of the polycomb repressive complex 2 for prostate cancer; and ORIC-114, a brain penetrant orally bioavailable irreversible inhibitor designed to selectively target epidermal growth factor receptor and human epidermal growth factor receptor 2 with high potency towards exon 20 insertion mutations. The company is also developing multiple discovery stage precision medicines targeting other cancer resistance mechanisms. ORIC Pharmaceuticals, Inc. has a license and collaboration agreement with Voronoi Inc.; a license agreement with Mirati Therapeutics, Inc.; and clinical development collaboration agreement with Pfizer Inc. The company was incorporated in 2014 and is headquartered in South San Francisco, California.", "fullTimeEmployees": 86, "companyOfficers": [{"maxAge": 1, "name": "Dr. Richard A. Heyman Ph.D.", "age": 65, "title": "Co-Founder, Independent Chairman & Member of Scientific Advisory Board", "yearBorn": 1957, "fiscalYear": 2022, "totalPay": {"raw": 93000, "fmt": "93k", "longFmt": "93,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Jacob M. Chacko M.B.A., M.D.", "age": 43, "title": "Pres, CEO & Director", "yearBorn": 1979, "fiscalYear": 2022, "totalPay": {"raw": 921321, "fmt": "921.32k", "longFmt": "921,321"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 3648645, "fmt": "3.65M", "longFmt": "3,648,645"}}, {"maxAge": 1, "name": "Mr. Dominic G. Piscitelli CPA, CPA, M.B.A.", "age": 47, "title": "Chief Financial Officer", "yearBorn": 1975, "fiscalYear": 2022, "totalPay": {"raw": 636913, "fmt": "636.91k", "longFmt": "636,913"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Pratik S. Multani M.D., M.S.", "age": 55, "title": "Chief Medical Officer", "yearBorn": 1967, "fiscalYear": 2022, "totalPay": {"raw": 686881, "fmt": "686.88k", "longFmt": "686,881"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 992063, "fmt": "992.06k", "longFmt": "992,063"}}, {"maxAge": 1, "name": "Dr. Charles L. Sawyers B.A., BA, M.D., Ph.D.", "age": 63, "title": "Co-Founder & Member of Scientific Advisory Board", "yearBorn": 1959, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Scott W. Lowe Ph.D.", "title": "Co-Founder & Member of Scientific Advisory Board", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Lori Sickels Friedman Ph.D.", "age": 58, "title": "Chief Scientific Officer", "yearBorn": 1964, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Christian V. Kuhlen Esq., J.D., M.D.", "age": 49, "title": "Gen. Counsel", "yearBorn": 1973, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Daniel  Iazzetti", "title": "VP & Head of People", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Edna  Chow Maneval", "age": 62, "title": "Sr. VP of Clinical Devel.", "yearBorn": 1960, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}